 NEW YORK, Aug. 04, 2020 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq:ITCI, a biopharmaceutical company focused on the development of and commercialization of therapeutics for central nervous system CNS disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Monday, August 10, 2020, to provide a corporate update and discuss details of the Companys financial results for the quarter ended June 30, 2020. To access the live conference call via phone, dial 1-844 835-6563. The international dial-in number is 1-970 315-3916. The conference ID number for the live call is 1574586.The live and archived webcast can be accessed under Events Presentations in the Investor Relations section of the Companys website at Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.About Intra-Cellular TherapiesIntra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit Therapies, Inc. Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations 646-440-9333Burns McClellan, Inc. Lisa Burns 212-213-0006 